By

Jan Becaus
May 20, 2021ByIn

Webinar: The revision of EU regulations on medicines for children and rare diseases 

Continue Reading
May 1, 2021ByIn

Civil society recommendations for improving the Orphan and Paediatric Regulations 

Joint_Recommendations_Paediatric_Orphan_Policy-dialogue_200521
Continue Reading
May 1, 2021ByIn

ECL’s contribution to the 2021 WHO Fair Pricing Forum 

2021-Fair-Pricing-Forum_ECL_contribution
Continue Reading
March 26, 2021ByIn

ECL welcomes the Council’s mandate to start negotiations on the HTA file

Continue Reading
March 21, 2021ByIn

ECL welcomes the Council’s agreement on a mandate to start negotiations on health technology assessments (HTA)

Continue Reading
February 11, 2021ByIn

European Commission’s accepts commitments by Aspen Pharmacare to cut prices for 6 critical cancer drugs

Continue Reading
December 1, 2020ByIn

Enabling informed decision-making about cancer screening participation

ECL_Second_Screening_Workshop_Dec_2020_final
Continue Reading
November 30, 2020ByIn

Webinar: Launch of the European Fair Pricing Network

Continue Reading
November 26, 2020ByIn

ECL welcomes Pharmaceutical Strategy’s ambitions to make medicines affordable and available for all patients

Continue Reading
November 23, 2020ByIn,

Managing cancer in the workplace: A handbook for employers and HR professionals 

Continue Reading
1 … 7 8 9 10 11 … 14